MedPath

云南生物谷药业股份有限公司

Ownership
-
Established
1999-06-13
Employees
-
Market Cap
-
Website
www.biovalley.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

灯盏细辛软胶囊

Approval Number
国药准字Z20070058
Approval Date
Jul 19, 2022
NMPA

Metoprolol Tartrate Injection

Product Name
酒石酸美托洛尔注射液
Approval Number
国药准字H20059619
Approval Date
Aug 4, 2020
NMPA

Sulfadiazine Sodium Injection

Product Name
磺胺嘧啶钠注射液
Approval Number
国药准字H53021597
Approval Date
Aug 4, 2020
NMPA

Chloramphenicol Injection

Product Name
氯霉素注射液
Approval Number
国药准字H53020416
Approval Date
Aug 4, 2020
NMPA

鱼腥草注射液

Approval Number
国药准字Z20043105
Approval Date
Aug 4, 2020
NMPA

灯盏花素注射液

Approval Number
国药准字Z20043106
Approval Date
Aug 4, 2020
NMPA

灯盏细辛注射液

Approval Number
国药准字Z53021620
Approval Date
Aug 4, 2020
NMPA

Ribavirin Injection

Product Name
利巴韦林注射液
Approval Number
国药准字H53021995
Approval Date
Aug 4, 2020
NMPA

Cis-platin Injection

Product Name
顺铂注射液
Approval Number
国药准字H20043888
Approval Date
Aug 4, 2020
NMPA

Propyl Gallate for Injection

Product Name
注射用棓丙酯
Approval Number
国药准字H20055374
Approval Date
Aug 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.